Alnylam Pharmaceuticals, Inc. (MM) Stock Price - ALNY

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last: $ 46.62 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type ISIN
Alnylam Pharmaceuticals, Inc. (MM) ALNY NASDAQ Common Stock US02043Q1076
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +0.37 +0.80% 46.62 47.15 45.00 45.90 46.25 17:23:57
Bid Price Ask Price Spread Spread % News
45.00 48.50 3.50 7.22% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
7,898 642,690 $ 46.0609 $ 29.6M 943.09k - - -
Last Trade Time Type Quantity Stock Price Currency
16:13:33 formt 600 $46.62 USD

Alnylam Pharmaceuticals, Inc. (MM) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 4.01B 86.01M $ -410.11M -4.79 0.00 50.93M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
9.55M $ 0.00 0.00% 37.11k 97.50%

more financials information »

Alnylam Pharmaceuticals, Inc. (MM) News

Date Time Source News Article
2/15/201717:09Edgar (US Regulatory)Annual Report (10-k)
2/14/201717:59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
2/14/201710:48Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
2/13/201708:41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
2/10/201716:00Business WireAlnylam Pharmaceuticals, Inc. Reports Inducement Grant Under..
2/09/201709:54Edgar (US Regulatory)Schedule 13g
2/09/201706:06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)

Historical ALNY Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week46.8648.5945.000.0000599k797k688k-0.24-0.51%
1 Month37.1748.5935.980.0000477k2M870k9.4525.42%
3 Months41.6048.5935.980.0000477k2M918k5.0212.07%
6 Months69.4380.1131.380.0000266k17M1M-22.81-32.85%
1 Year57.7280.1131.380.0000266k17M1M-11.10-19.23%
3 Years86.94140.0031.380.0000017M844k-40.32-46.38%
5 Years13.58140.009.510.0000017M716k33.04243.30%

Alnylam Pharmaceuticals, Inc. (MM) Description

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating the expression of specific genes.
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20170225 18:09:03